Literature DB >> 994550

Bypass surgery for vascular disease of the carotid system.

T M Sundt, R G Siekert, D G Piepgras, F W Sharbrough, O W Houser.   

Abstract

A series of 58 operations on 56 patients, in whom a branch of the superficial temporal artery was anastomosed to a branch of the middle cerebral artery (STA-MCA bypass or Yasargil procedure), is reviewed. These operations were performed chiefly for occlussions or for inaccessible stenotic lesions of the internal carotid or middle cerebral arteries. Patency in eight patients operated on from April 1971 through November 1973 was low (25%). Patency in patients operated on since July 1974 has been high (95%). There have been no deaths and no major ischemic strokes attributable to the surgery. The rationale for this procedure is considered in relationship to the anatomy and physiology of the cerebral circulation and the pathogenesis of syndromes of cerebral ischemia. The operation appears to have a low morbidity in good-risk patients. The role of this operation in managing common manifestations of cerebral vascular disease such as focal transient cerebral ischemic attacks (TIAs) and amaurosis fugax, although not fully established, appears encouraging. The procedure seems useful for orthostatic cerebral ischemia caused by multiple occlusions of major extracranial (and intracranial) vessels and, occasionally, for progressing strokes related to internal carotid artery occlusion, both of which are relatively uncommon manifestations of cerebral vascular occlusive disease. It may have application in the rare "slow stroke." The procedure is probably of limited value, if any, in the management of large completed infarcts but may be indicated in selected patients with small infarctions who have preserved most of their cerebral function and who have had evidence of subsequent focal ischemic events. The procedure is useful for bypassing giant aneurysms or basofrontal tumors invading major vessels. It may have a role in the management of fibromuscular disease of the internal carotid artery.

Entities:  

Mesh:

Year:  1976        PMID: 994550

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  23 in total

1.  SUPERFICIAL TEMPORAL MIDDLE CEREBRAL BYPASS: A TECHNIQUE FOR RELIEVING CEREBROVASCULAR INSUFFICIENCY.

Authors:  Enrique Raso; L Paul Gerson
Journal:  Cardiovasc Dis       Date:  1979-09

Review 2.  Extracranial-intracranial bypass to reduce the risk of ischemic stroke.

Authors:  T V Holohan
Journal:  CMAJ       Date:  1991-06-01       Impact factor: 8.262

3.  Reactivity of the cerebral circulation in patients with carotid occlusion.

Authors:  M M Brown; J P Wade; C C Bishop; R W Russell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

4.  The ocular aspects of carotid artery bypass surgery.

Authors:  T P Kearns; R G Siekert; T M Sundt
Journal:  Trans Am Ophthalmol Soc       Date:  1978

5.  Superficial temporal artery to middle cerebral artery bypass.

Authors:  David W Newell
Journal:  Skull Base       Date:  2005-05

6.  Primary orthostatic cerebral ischaemia.

Authors:  R J Stark; J Wodak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-10       Impact factor: 10.154

7.  Bypass and transluminal dilatation procedures for advanced occlusive disease of the posterior circulation.

Authors:  T M Sundt; H C Smith; D G Piepgras; J K Campbell
Journal:  Neurosurg Rev       Date:  1982       Impact factor: 3.042

8.  Angiographic technique in extra-intracranial arterial bypass for cerebral ischemia.

Authors:  A F Marliani; A Andreoli; C Testa
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

Review 9.  Strokes, transient ischemic attacks and asymptomatic bruits.

Authors:  H I Machleder
Journal:  West J Med       Date:  1979-03

10.  Superficial temporal-middle cerebral artery anastomosis in Moyamoya disease.

Authors:  K H Holbach; H Wassmann; J Wappenschmidt
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.